Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Endocrine-Disrupting Chemicals Endanger Human Health

By HospiMedica International staff writers
Posted on 28 Dec 2014
A new guide documents the threat endocrine-disrupting chemicals (EDCs) poses to rising rates of male birth defects, infertility, cancer, obesity, and neurobehavioral disorders.

Released by the Endocrine Society (Washington DC, USA) and the International POPs Elimination Network (IPEN), the new guide explores the burgeoning scientific evidence—based on field research in wildlife species, epidemiological data on humans, and laboratory research with cell cultures and animal models—that provides insights into how EDCs cause biological changes, and how that may lead to disease. More...
Chemicals such as polychlorinated biphenyls (PCBs), BPA, and phthalates, are now detectable in serum, fat, and umbilical cord blood in humans around the globe.

The guide stresses that rather than the old toxicological method of a single-exposure, dose-response approach using pure compounds, it is vital that new risk assessment procedures simulate more closely what occurs in nature, i.e., the effects of combinations of compounds or mixtures. It is also vital to recognize that because certain life stages are particularly vulnerable to EDCs, especially early in development, testing EDC effects on adults, which is the norm in traditional risk assessment, may not extrapolate to the exposed fetus or infant.

“There is good reason to suspect that increasing chemical production and use is related to the growing incidence of endocrine-associated disorders over the past 20 years,” said lead author Andrea Gore, PhD, of the University of Texas (Austin, USA). “Importantly, there is growing evidence that fetuses and children have a particular vulnerability to these chemicals. Introduction to EDCs was written to help policymakers and others better understand how these chemicals work and to assist them in making informed policy decisions.”

“The international community will decide how to respond to regional recommendations and growing stakeholder concerns about EDCs,” said Olga Speranskaya, PhD and co-chair of IPEN. “Some of our goals for the meeting include new initiatives to identify potential EDCs and safer alternatives including non-chemical alternatives, more awareness-raising about the hazards of EDCs, and steps toward translating research results into control actions.”

EDCs and other Persistent Organic Pollutants (POPs) were one of the topics of discussion when policymakers and other stakeholders met in Geneva (Switzerland) during December 2014 to discuss the next steps on the Strategic Approach to International Chemicals Management (SAICM), a global chemical safety policy framework. More than 100 countries are participating in the process, which is organized by the United Nations Environment Program (UNEP; Nairobi, Kenya) with contributions from the World Health Organization (WHO).

Related Links:

The Endocrine Society
International POPs Elimination Network
University of Texas



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.